The data from the Phase 1/1b clinical trial of soquelitinib in patients with T cell lymphoma continues to demonstrate strong indications of anti-tumor activity in a significant number of patients,” ...

Be, the leader in web accessibility solutions, today announced that it has expanded its product offerings with the launch of manual testing and custom remediation (MTCR). This capability combines ...

AI-enhanced glucose monitoring provides predictive analytics and personalized insights for better blood sugar management.